Our pre-clinical facility (PCF) undertakes a wide range of studies, including regulatory toxicity – which are required for filing Investigational New Drug (IND) applications. A number of new screening facilities and biological evaluation models have been set up to support the drug discovery and development process.
A wide range of animal toxicology, microbiology and pharmacology studies are also undertaken to confirm the safety and efficacy of molecules. The facility is registered with the committee for the Purpose of Control and Supervision of Experiment on Animals (CPCSEA), Ministry of Environment & Forests and the Government of India. Additionally, an Institutional Animal Ethics Committee (IAEC) monitors our research for issues related to animal welfare and experimentation. Work quality standards are in compliance with US Food Drug Administration (US FDA) and the Organisation for Economic Co-operation Development (OECD) principles of Good Laboratory Practice (GLP).